Monsanto (MON) Earns Media Impact Rating of 0.08

News articles about Monsanto (NYSE:MON) have been trending somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Monsanto earned a news impact score of 0.08 on Accern’s scale. Accern also gave news coverage about the basic materials company an impact score of 44.6021498548501 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

Several equities analysts recently weighed in on the stock. Wells Fargo & Co reaffirmed a “market perform” rating and issued a $128.00 price target (up previously from $118.00) on shares of Monsanto in a research report on Wednesday. Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research report on Tuesday. Barclays reaffirmed an “equal weight” rating and issued a $124.00 price target (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. BMO Capital Markets reaffirmed a “buy” rating and issued a $128.00 price target on shares of Monsanto in a research report on Thursday, October 5th. Finally, Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a research note on Wednesday, October 4th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $127.30.

Monsanto (NYSE:MON) traded up $1.80 during trading hours on Friday, reaching $120.66. 6,983,227 shares of the company’s stock traded hands, compared to its average volume of 3,070,000. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28. The stock has a market cap of $53,110.00, a price-to-earnings ratio of 22.30, a price-to-earnings-growth ratio of 1.70 and a beta of 1.04. Monsanto has a 52-week low of $106.97 and a 52-week high of $122.79.

Monsanto (NYSE:MON) last posted its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). The firm had revenue of $2.66 billion during the quarter, compared to analysts’ expectations of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The company’s quarterly revenue was up .3% on a year-over-year basis. During the same quarter last year, the business posted $0.21 EPS. analysts expect that Monsanto will post 5.76 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 annualized dividend and a yield of 1.79%. Monsanto’s dividend payout ratio (DPR) is 39.93%.

In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The transaction was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 0.79% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This article was originally published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this article on another domain, it was stolen and reposted in violation of international copyright and trademark laws. The original version of this article can be accessed at

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Insider Buying and Selling by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply